H. Herschlein

发表

[Symptom-oriented follow-up of early breast cancer compared to intensive surveillance. Results of a prospective multicentre study: update and 10-year overall survival].

C. Meisner, W. Simon, B. Schmidt, 2012, Deutsche medizinische Wochenschrift.

Does Adjuvant Systemic Therapy Improve Prognosis in Breast Cancer with 4-9 Axillary Nodes and in the Age Group of 80 Years or More?

C. Meisner, P. Jipp, K. Littmann, 1998, Oncology Research and Treatment.

Symptom-Oriented Follow-Up of Early Breast Cancer Is not Inferior to Conventional Control. Results of a Prospective Multicentre Study

C. Meisner, W. Simon, W. Aulitzky, 2007, Oncology Research and Treatment.

[The serum protein picture in obstetrical afibrinogenemia. Dysproteinemia as a consequence of uncoagulable fibrinogen derivatives].

H. Herschlein, D. Steichele, I. Woerner, 1966, Klinische Wochenschrift.

Die Vaginaefixatio sacrospinalis vaginalis mit Mesh-Interponat zur Korrektur der Enterozele Eine sichere Alternative?

Ä. Direktor, H. Herschlein, 2007 .

[Acitivity of physiological inhibitors of blood coagulation and fibrinolysis during pregnancy, labor, and in the puerperium. Immunological studies].

H. Herschlein, E. Kidess, D. Steichele, 1973, Die Medizinische Welt.

[The diagnosis and treatment of pelvic adhesions causing recurrent pelvic pain in cases with normal findings on pelvic palpation (author's transl)].

W. Lechner, H. Herschlein, 1974, Geburtshilfe und Frauenheilkunde.

[The response of venous vascular tone, orthostatic regulatory capacity and clotting potential under the influence of an ovulation inhibitor].

H. Rieckert, H. Herschlein, K. Brecht, 1970, Archiv fur Gynakologie.

[Clinical aspects and therapy of hemorrhage caused by fibrinolysis and fibrinogenolysis].

H. Herschlein, F. Steichele, 1962, Die Medizinische Welt.

[Studies on fibrinolytic activity and alpha I antitrypsin in the human ovary and the ovarian carcinoma as well as in hydatidiform moles].

H. Herschlein, E. Kidess, S. Kunz, 1973, Die Medizinische Welt.